MET and neoplasm: This may be consistent with the biological pathways involved in tumor-to-stroma relation, resulting in downstream activation of multiple kinases, stimulated by the interaction between the stroma-secreted ligand HGF (Hepatocyte Growth Factor) and ‘onco-receptor’ MET (Hepatocyte Growth Factor Receptor) [40].